News
'Hard to know what's going to happen': Big Pharmas put brave face on looming tariff threat
The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff on pharmaceuticals. | The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed threat of a tariff on pharmaceuticals.
The U.S. is Europe and Britain’s largest export market. About 20% of EU exports go to the U.S. at a value of around $581 billion. Europe’s trade doesn’t immediately have anywhere else to go.
Bessent's victory lap on tariff revenues was premature. And so are hopes that the trade war won't damage commerce and the U.S. economy.
President Donald Trump said he planned to implement a 50% duty on copper imports as part of a set of looming sectoral tariffs ...
CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of tariffs this year.
Trump has announced reciprocal tariffs on dozens of American trading partners, as well as new tariffs on copper and ...
Healthcare costs are already expensive for many. In some states, tariff-related price hikes are showing up in 2026 rate ...
Johnson & Johnson expects a smaller hit from tariffs than it predicted earlier in the year, despite uncertainty over the prospects of new U.S. levies on pharmaceuticals. J&J now predicts tariffs will ...
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback